New #Stocks to Watch at Investor Ideas – Biotech (NASDAQ:
$AZYO), Sports (NASDAQ: $ASO), Cleantech (NASDAQ: $ARRY), CBD (NASDAQ: $JUPW)
Point Roberts WA, Delta BC, October 23, 2020 –
(Investorideas.com Newswire) Investorideas.com, a global news source and
leading retail investor and trader resource, announces its weekly roundup of
stocks to watch. Today’s stocks in Biotech, Sports, Cleantech, Cannabis,
Agriculture, Real Estate and China-Asia have been added to our list of free
stock directories in each sector.
Read this in full at https://www.investorideas.com/news/2020/main/10231Stocks.asp
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.
All new companies added
this week are October IPO’s.
The latest biotech
companies are involved in biopharmaceuticals, medical devices and biotechnology
medicines.
The newest sports companies
are involved in live TV sports streaming and sporting goods while the latest
cleantech company is solar-related and the newest cannabis company is looking
at CBD therapies.
The newest agriculture
company is involved with avocado production and distribution, the real estate company
is focused on its commercial property REIT portfolio and the China-Asia company
is in childhood edutainment.
New Stocks added to Biotech stocks directory:
AZIYO BIOLOGICS, INC. (NasdaqGS:AZYO) is a commercial-stage regenerative medicine
company focused on creating the next generation of differentiated products and
improving outcomes in patients undergoing surgery, concentrating on patients
receiving implantable medical devices. Since its founding in 2015, the Company
has created a portfolio of commercial-stage products used in cardiovascular,
orthopedic, and reconstructive specialties.
Pulmonx Corp (NasdaqGS:LUNG) is a commercial-stage medical technology company
focused on providing planning tools and treatments for obstructive lung
disease. Our solution is comprised of the Zephyr® Valve, Chartis® Pulmonary
Assessment System and StratX® Lung Analysis Platform, and is designed to
address the need for a more effective, minimally invasive treatment option for
patients with severe emphysema, a form of chronic obstructive pulmonary disease
(COPD). Specifically, our solution provides bronchoscopic lung volume reduction
without surgery and its associated risks. It is used to treat patients who,
despite medical management, are still profoundly symptomatic and either do not
want or are ineligible for surgical approaches.
C4 Therapeutics, Inc. (NasdaqGS:CCCC) is a biopharmaceutical company focused on
harnessing the body’s natural regulation of protein levels to develop novel
therapeutic candidates to target and destroy disease-causing proteins for the
treatment of cancer, neurodegenerative conditions and other diseases.
Shattuck Labs, Inc. (NasdaqGS:STTK) is a clinical-stage biotechnology company pioneering the development of
bi-functional fusion proteins as a new class of biologic medicine for the
treatment of cancer and autoimmune disease. Compounds derived from Shattuck’s
ARC platform simultaneously inhibit checkpoint molecules and activate
costimulatory molecules within a single therapeutic. The company’s lead wholly
owned program, SL-172154 (SIRPα-Fc-CD40L), which is designed to block the CD47
immune checkpoint and simultaneously agonize the CD40 pathway, is being
evaluated in a Phase 1 trial. A second compound, SL-279252 (PD1-Fc-OX40L), is
being evaluated in a Phase 1 trial in collaboration with Takeda
Pharmaceuticals. Additionally, the company is advancing a proprietary Gamma
Delta T Cell Engager platform, GADLEN™, which is designed to bridge gamma delta
T cells to tumor antigens for the treatment of cancer. Shattuck has offices in
both Durham, North Carolina and Austin, Texas.
SPRUCE BIOSCIENCES, INC. (NasdaqGS:SPRB) is a late-stage
biopharmaceutical company focused on developing and commercializing novel
therapies for rare endocrine disorders with significant unmet need. Spruce is
initially developing its wholly-owned product candidate, tildacerfont, as the
potential first non-steroidal therapy to offer markedly improved disease
control and reduce steroid burden for patients suffering from classic
congenital adrenal hyperplasia (CAH). Classic CAH is a serious and
life-threatening disease with no known novel therapies approved in
approximately 50 years.
Kronos Bio, Inc. (NasdaqGS:KRON) is a clinical-stage biopharmaceutical company dedicated to the discovery
and development of novel cancer therapeutics designed to transform patient
outcomes by targeting dysregulated transcription. The company has headquarters
in San Mateo, Calif., and a research facility in Cambridge, Mass.
Oncorus,
Inc. (NasdaqGS:ONCR) is a clinical stage biopharmaceutical company
focused on developing next-generation viral immunotherapies to transform
outcomes for cancer patients. Using its two distinct proprietary platforms, the
Company is developing a pipeline of intratumorally and intravenously
administered product candidates designed to selectively attack and kill tumor
cells and stimulate multiple arms of the immune system against tumors. Oncorus’
lead product candidate, ONCR-177, is an intratumorally administered viral
immunotherapy based on its oncolytic HSV-1 platform, referred to as the oHSV Platform,
which leverages the Herpes Simplex Virus type 1, or HSV-1, a virus which has
been clinically proven to effectively treat certain cancers
Codiak
BioSciences, Inc. (NasdaqGS:CDAK) is a clinical-stage
biopharmaceutical company focused on pioneering the development of
exosome-based therapeutics, a new class of medicines with the potential to
transform the treatment of a wide spectrum of diseases with high unmet medical
need. By leveraging the biology of exosomes as natural intercellular transfer
mechanisms, Codiak has developed its proprietary engEx Platform to expand upon
the innate properties of exosomes to design, engineer and manufacture novel
exosome therapeutic candidates. Codiak has utilized its engEx Platform to
generate a deep pipeline of engineered exosomes aimed at treating a broad range
of disease areas, spanning oncology, neuro-oncology, neurology, neuromuscular
disease and infectious disease.
Immunome Inc. (NasdaqCM:IMNM) is a biopharmaceutical
company utilizing a proprietary human memory B cell platform to discover and develop
first-in-class antibody therapeutics designed to change the way diseases are
currently being treated and an initial focus on oncology and infectious
diseases, including COVID-19. Immunome’s proprietary discovery platform
identifies novel therapeutic antibodies and their targets by leveraging highly
educated components of the immune system, memory B cells, from patients who
have learned to fight off their disease
New Stocks added to Sports stocks directory:
Academy
Sports & Outdoors, Inc. (NasdaqGS:ASO) is one of the leading
full-line sporting goods and outdoor recreation retailers in the United States.
Originally founded in 1938 as a family business in Texas, Academy has grown to
259 stores across 16 contiguous states, primarily in the southern United
States. Academy's mission is to provide "Fun for All" and Academy fulfills
this mission with a localized merchandising strategy and value proposition that
strongly connects with a broad range of consumers. Academy's product assortment
focuses on key categories of outdoor, apparel, footwear and sports &
recreation through both leading national brands and a portfolio of 17 private
label brands, which go well beyond traditional sporting goods and apparel
offerings.
fuboTV Inc. (NYSE:FUBO) is the leading sports-first
live TV streaming platform offering subscribers access to tens of thousands of
live sporting events annually as well as leading news and entertainment
content. fuboTV’s base package, fubo Standard, features a broad mix of 100+
channels, including 43 of the top 50 Nielsen-ranked networks across sports,
news and entertainment (Primetime A18-49). Continually innovating to give
subscribers a premium viewing experience they can’t find with cable TV, fuboTV
is regularly first-to-market with new product features and was the first
virtual MVPD to stream in 4K. fuboTV merged with FaceBank Group in April 2020
to create a leading digital entertainment company, combining fuboTV’s
direct-to-consumer live TV streaming platform for cord-cutters with FaceBank’s
technology-driven IP in sports, movies and live performances.
New Stocks added to Cleantech stocks directory:
ARRAY
Technologies Inc. (NasdaqGS:ARRY) is one of the world’s largest
manufacturers of ground-mounting systems used in solar energy projects. The
Company’s principal product is an integrated system of steel supports, electric
motors, gearboxes, electronic controllers and software, commonly referred to as
a single-axis “tracker.” Trackers move solar panels throughout the day to
maintain an optimal orientation to the sun, which significantly increases their
energy production. Solar energy projects that use trackers generate up to 25%
more energy and deliver a lower levelized cost of energy than projects that use
conventional “fixed tilt” mounting systems. Array Technologies is headquartered
in the United States with offices in Europe, Central America, and Australia.
New Stocks added to Cannabis stocks directory:
Jupiter Wellness, Inc.
(NasdaqCM:JUPW) is a functional wellness and
natural health products company. With a tireless devotion to quality, sourcing,
and customer care, our goal is to harness the scientifically-backed health
benefits of CBD like arthritis relief and muscle relaxation to help the
population live a more fulfilling life through a variety of forthcoming
products.
New Stocks added to Agriculture/Food stocks directory:
Mission Produce, Inc. (NasdaqGS:AVO) is a world leader in sourcing, producing and
distributing fresh avocados, servicing retail, wholesale and foodservice
customers in over 25 countries. The Company’s operations consist of four
packing facilities in the United States, Mexico and Peru, 11 distribution and
ripening centers across the U.S., Canada, China and the Netherlands, as well as
three sales offices in the U.S., China and the Netherlands.
New Stocks added to Real Estate stocks directory:
Presidio
Property Trust, Inc. (NasdaqGS:SQFT) is an internally managed, diversified REIT. Our
commercial real estate portfolio consists of approximately 1.1 million square
feet comprised of 15 properties: 10 office properties, one industrial property
and four retail properties. Our commercial portfolio is located in Southern
California, Colorado, and North Dakota, and we are currently considering new
commercial property acquisitions in a variety of additional markets across the
United States. Our commercial property tenant base is diversified, which helps
limit our exposure to any single industry in which our tenants operate.
Additionally, we own approximately 130 model home properties located in seven
states, with the majority located in Texas and Florida. This geographical
clustering of our real estate portfolio enables us to minimize operating costs
and leverage efficiencies by managing a number of properties utilizing minimal
overhead and staff.
New Stocks added to China-Asia stocks directory:
iHuman Inc. (NYSE:IH) is a leading childhood edutainment company in China that is
committed to transforming learning into a fun journey for every child.
Benefiting from a legacy that combines a strong educational foundation and
decades of experience in childhood education with cutting edge technology and
an outstanding reputation for original entertainment content, iHuman provides
children with unique, interactive, and entertaining learning experiences. The
Company's comprehensive suite of innovative and high-quality products and
services caters to the educational needs of kids at school and at home, both
online and offline, and covers diverse subjects, including Chinese learning,
English, mathematics and critical thinking, literacy and reading, Chinese
culture, STEM and other subjects. iHuman's line-up of highly effective
edutainment products and services include interactive and self-directed
learning apps, as well as learning materials and smart learning devices. With
solid pedagogy, deep understanding of children's education and psychology, as
well as advanced technology capabilities in gamification, AI/AR technologies,
and big data analysis, iHuman believes it will continue to provide learning
experiences that are both educational and fun for children in China and all
over the world through its integrated suite of childhood edutainment products
and services.
The directories are not meant as recommendations
but as a research tool to discover opportunities and trading ideas in a
particular sector.
About
Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a
recognized news source publishing third party news and press releases, research
and our own original financial content. We were one of the first retail
investor sites to cover renewable energy and cleantech stocks at
investorideas.com and our domain Renewableenergystocks.com. We were also one of
the most well- known and cited defense stock sites, featuring our domain Homelanddefensestocks.com
at its peak.
We follow the money for
investors as sector sentiment shifts and technology disrupts. Our mission is to
provide investor ideas with breaking news, resources, industry articles and
interviews with leading experts.
Learn about investing in
stocks and sector trends with our news alerts, articles, podcasts and videos, looking
at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable
energy and more. Investor Idea's original branded content includes the
following podcasts and columns: Crypto
Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining and the AI Eye.
Public companies within the
sectors we cover use our news and content services to
tell their story to interested investors. Paid for content is
disclosed.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of
third party sourced news, articles and equity research as well as creates
original content, including video, interviews and articles. Original content
created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investing involves risk
and possible losses. This site is currently compensated for news publication
and distribution, social media and marketing, content creation and more.
Disclosure is posted for each compensated news release, content published
/created if required but otherwise the news was not compensated for and was
published for the sole interest of our readers and followers. Contact
management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news
services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Learn more about our news, PR and social media,
podcast and ticker tag services at Investorideas.com
https://www.investorideas.com/Investors/Services.asp
Learn more about advertising and guest posts
https://www.investorideas.com/Advertise/
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club
https://www.investorideas.com/membership/
Contact
Investorideas.com
800 665 0411
